相关实验视频

Updated: Jan 8, 2026

Intracranial Cannula Implantation for Serial Locoregional Chimeric Antigen Receptor CAR T Cell Infusions in Mice

Intracranial Cannula Implantation for Serial Locoregional Chimeric Antigen Receptor CAR T Cell Infusions in Mice

Published on: February 24, 2023

治疗神经系统疾病的CAR T细胞疗法:科学理由和机制性见解

Dimitrios E Katsaros¹, Dimitrios Mougiakakos²

¹Department of Hematology, Oncology, and Cell Therapy, Otto-von-Guericke University Magdeburg, Magdeburg, Germany.

Therapeutic advances in neurological disorders

|December 15, 2025

概括

化学抗原受体 (CAR) T细胞疗法是一种癌症治疗方法,现在对自身免疫性疾病 (AIDs) 显示出希望. 研究正在改进CAR T细胞,以提高神经性艾滋病治疗的安全性,有效性和可访问性.

科学领域:

免疫学免疫学免疫学
在瘤学瘤学.
神经学神经学

背景情况:

化学抗原受体 (CAR) T细胞疗法通过设计T细胞以向特定抗原来彻底改变癌症治疗.
在改善CAR T细胞的安全性,有效性,制造和成本效益方面取得了重大进展.
目前正在探索CAR T细胞治疗自身免疫性疾病 (AIDs),主要通过B细胞枯竭来治疗.

研究的目的:

审查CAR T细胞治疗的机制和演变.
突出CAR T细胞治疗在治疗自身免疫性疾病,特别是神经性艾滋病的潜力.
讨论在艾滋病治疗中实施CAR T细胞治疗的考虑因素.

主要方法:

对癌症和自身免疫性疾病中CAR T细胞疗法的现有文献的综述.
分析CAR T细胞结构的重新设计和制造改进.
检查神经性AIDs的临床经验和正在进行的试验.

主要成果:

卡尔T细胞疗法显示出治疗B细胞介导艾滋病的潜力,包括神经疾病.
早期的临床数据表明,CAR T细胞在耐火性脑筋硬化症,兰伯特-伊顿综合征,多发性硬化症和刚性人群综合征中具有有希望的疗效和耐受性.
越来越多的临床试验正在研究神经性艾滋病的CAR T细胞疗法.

结论:

卡尔T细胞疗法是对自身免疫性疾病的非常有前途的策略,特别是在神经学领域.
需要进一步的研究和临床试验,以优化对艾滋病的CAR T细胞疗法.
解决制造挑战和毒性概况对于广泛采用至关重要.

关键词:

B细胞的枯竭是B细胞的枯竭汽车汽车汽车汽车自身免疫性疾病自身免疫性疾病细胞治疗疗法细胞治疗疗法神经免疫学神经免疫学重置重置是一个重置.

更多相关视频

Generation of Human Chimeric Antigen Receptor Regulatory T Cells

Generation of Human Chimeric Antigen Receptor Regulatory T Cells

Published on: January 3, 2025

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Published on: February 16, 2015

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...